Capital vs Operating Budget in Healthcare Purchasing

Which budget a purchase lands in decides the calendar, the approver, and often whether it happens this year at all. It is frequently decided by accident.

Updated September 18, 2026

The short answer

Capital purchases are approved on an annual cycle tied to the fiscal year and compete against every other capital request; miss the window and the request usually waits a year. Operating purchases are approved by the department holding the budget, without the annual calendar, but against tighter discretionary limits and renewed scrutiny every year. Pricing a product into one or the other changes the buyer, the timeline, and the approval threshold.

Explained at three levels

1 Plain English

Hospitals keep two kinds of money. One is for things they buy and own for years, like a scanner. That money is handed out once a year, all at once, and everybody competes for it. The other is for things they pay for as they go, like subscriptions and supplies. That money belongs to individual departments and does not wait for an annual meeting.

2 Informed buyer

The capital threshold varies by organization, commonly somewhere between five thousand and one hundred thousand dollars, and is set locally. Above it, a purchase joins the annual capital request process, gets ranked against clinical and infrastructure needs across the whole organization, and is funded or not. Supplemental and emergency capital exists but draws from a much smaller pool with a higher justification bar.

3 Technical and professional detail

Accounting treatment is not a preference and cannot simply be chosen. Whether something is capitalized depends on the nature of the arrangement, not on which budget is more convenient. Implementation and configuration effort associated with a subscription is treated differently from the subscription itself, and different organizations reach different conclusions about the same contract. This is a question for the buyer’s finance office, and a vendor who pretends otherwise creates a problem later.

Why this decides the calendar

Capital runs on the fiscal year. Requests are collected, ranked, and funded in a defined window, and a request that arrives after it usually waits for the next one regardless of merit.

That produces a specific and avoidable failure: a vendor runs an excellent evaluation cycle, wins on merit, and discovers the capital window closed two months ago. Nothing about the outcome was wrong. The timing was.

Operating has no equivalent gate. A department head can move within their own budget. But that budget is smaller and already committed, and a recurring subscription reappears in every budget cycle for as long as it exists, which means it has to keep justifying itself indefinitely.

The tradeoff, plainly

A subscription is easier to start and harder to keep. Capital is harder to start and then largely disappears into depreciation.

That framing is more useful than the usual "software should be operating expense" advice, because it names the actual cost of each route. Vendors who reprice deliberately understand they are trading a hard first approval for an easier one followed by an annual renewal argument.

Where it goes wrong

Three recurring patterns.

Routing to operating to dodge the capital calendar. It works right up until the amount exceeds what the department head can approve alone, at which point it escalates anyway, having skipped the process built for escalation.

Assuming a pilot price sets the conversion price. A discounted or free trial is often approved out of a discretionary line without much scrutiny. The conversion at full price crosses a threshold that triggers a completely different review, with people who have never heard of the product.

Quoting a price that excludes the implementation. Interface build, internal analyst time, and training are real money and they land somewhere. If the vendor has not accounted for them, finance will, and the number they produce is the one that gets evaluated.

What to ask, and when

Early in the conversation, three questions save months:

Is this likely to be capital or operating for you, and who decides that?
When does your capital request window open and close?
At what dollar amount does this stop being something you can approve?

None of these is a rude question. All three are asked routinely by people who have sold into health systems before, and the absence of them is a reliable signal that a vendor has not.

Where this goes next

Topics: budget, capital, finance, procurement